GlassScriptPhysician profile
Matthew A Sandretti
NPI 1508276460
$3,521.95
in general payments reported to CMS, 2019-2025
9 companies · $1,370 in 2025
The $1,370 reported for 2025 was more than what 93% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.54 · 2020: $124 · 2021: $90.53 · 2022: $95.99 · 2023: $1,275 · 2024: $522 · 2025: $1,370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,837 · Travel and Lodging: $821 · Entertainment: $353 · Consulting Fee: $150 · Gift: $4.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,837.35 |
| Travel and Lodging | $820.92 |
| Entertainment | $353.30 |
| Consulting Fee | $150.00 |
| Gift | $4.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,932.88 | 2020-2024 | Invisalign, Touch Up |
| American Orthodontics Corporation | $1,250.27 | 2025 | LP and Ifit Tubes, Radiance, Empower-Ceramic |
| Envista Holdings Corporation | $126.45 | 2024-2025 | Spark |
| Ormco Corporation | $61.05 | 2020-2023 | Spark, Miniendo II |
| Solventum Corporation | $45.23 | 2025 | Clarity Aligners, Clarity Advanced |
| Nobel Biocare USA | $44.63 | 2023 | Nobelactive |
| 3m Company | $43.21 | 2019-2021 | |
| Henry Schein, INC. | $15.00 | 2019 | |
| Ultradent Products INC | $3.23 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Sandretti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.